Hemostemix
AB - CalgaryBiotechnology
Focus: Hemostemix is a Calgary-based biotechnology company specializing in autologous cell therapy, focusing on gene therapy and cell therapy modalities. The company operates at a pre-revenue stage with a single Phase 2 program in clinical development.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Open Jobs
0
About Hemostemix
AI assessmentNot HiringNo open roles listed right now. Follow Hemostemix to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ACP-01
Critical Limb IschemiaClinical Trials (1)
NCT02551679ACP-01 in Patients With Critical Limb Ischemia
Phase 2Help build intelligence for Hemostemix
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.